Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aringer

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Zeitschrift Fur Rheumatologie|January 19, 2017
[Tapering and termination of immunosuppressive therapy : Systemic lupus erythematosus]M Aringer, N Leuchten, R Fischer-Betz
Zeitschrift Fur Rheumatologie|July 16, 2016
[Inflammasome and gout]M Aringer, C Hedrich, A-K Tausche
Zeitschrift Fur Rheumatologie|July 19, 2012
[Local and systemic bone effects of rheumatoid arthritis]M Rauner, L C Hofbauer, M Aringer
Atherosclerosis. Supplements|January 30, 2013
Immunoadsorption for connective tissue diseaseB Hohenstein, S R Bornstein, M Aringer
Zeitschrift Fur Rheumatologie|January 21, 2016
[Influence of therapy on risk of cancer in rheumatoid arthritis. Pathophysiological principles]M J Waldner, A Strangfeld, M Aringer
Zeitschrift Fur Rheumatologie|July 30, 2017
[Still's disease in children and adults]C M Hedrich, C Günther, M Aringer
Zeitschrift Fur Rheumatologie|January 21, 2016
[Genitourinary malignancies and rheumatoid arthritis]M Boegemann, R Alten, M Aringer, et al.
Arthritis and Rheumatism|March 20, 1998
Severe infections in plasmapheresis-treated systemic lupus erythematosusM Aringer, J S Smolen, W B Graninger
Clinical and Experimental Rheumatology|November 21, 2007
The central role of T cells in rheumatoid arthritisA P Cope, H Schulze-Koops, M Aringer
Arthritis and Rheumatism|July 24, 2001
Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by PisetskyM Aringer, G Steiner, W Graninger, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Zeitschrift Fur Rheumatologie|January 19, 2017
[Tapering and termination of immunosuppressive therapy : Systemic lupus erythematosus]M Aringer, N Leuchten, R Fischer-Betz
Zeitschrift Fur Rheumatologie|July 16, 2016
[Inflammasome and gout]M Aringer, C Hedrich, A-K Tausche
Zeitschrift Fur Rheumatologie|July 19, 2012
[Local and systemic bone effects of rheumatoid arthritis]M Rauner, L C Hofbauer, M Aringer
Atherosclerosis. Supplements|January 30, 2013
Immunoadsorption for connective tissue diseaseB Hohenstein, S R Bornstein, M Aringer
Zeitschrift Fur Rheumatologie|January 21, 2016
[Influence of therapy on risk of cancer in rheumatoid arthritis. Pathophysiological principles]M J Waldner, A Strangfeld, M Aringer
Zeitschrift Fur Rheumatologie|July 30, 2017
[Still's disease in children and adults]C M Hedrich, C Günther, M Aringer
Zeitschrift Fur Rheumatologie|January 21, 2016
[Genitourinary malignancies and rheumatoid arthritis]M Boegemann, R Alten, M Aringer, et al.
Arthritis and Rheumatism|March 20, 1998
Severe infections in plasmapheresis-treated systemic lupus erythematosusM Aringer, J S Smolen, W B Graninger
Clinical and Experimental Rheumatology|November 21, 2007
The central role of T cells in rheumatoid arthritisA P Cope, H Schulze-Koops, M Aringer
Arthritis and Rheumatism|July 24, 2001
Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by PisetskyM Aringer, G Steiner, W Graninger, et al.
Pageof 10